Finance

Lists
Why is 524711 down 4,23%?
Dive Deeper
524711:BOM
Vista Pharmaceuticals Ltd
₹6,11
-4,23%
(-0,27) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524711...
Open
₹6,32
High
₹6,34
Low
₹6,11
Mkt. cap
376,08 m
Avg. vol.
11,31 k
Volume
6,54 k
52-wk high
₹10,50
52-wk low
₹5,32
EPS
-₹1,90
Shares outstanding
29,15 m
No. of employees
30
Open
₹6,32
High
₹6,34
Low
₹6,11
Mkt. cap
376,08 m
Avg. vol.
11,31 k
Volume
6,54 k
52-wk high
₹10,50
52-wk low
₹5,32
EPS
-₹1,90
Shares outstanding
29,15 m
No. of employees
30
News stories
From web sources and news partners
About Vista Pharmaceuticals Ltd
CEO-
Employees30
Founded1991
Headquarters-
SectorPharmaceutical industry
Last report
13 Feb. 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (INR)
24,18 m / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Jun. 2025
Sep. 2025
Des. 2025
Jun. 2026
Revenue
15,19 m
14,62 m
24,18 m
-
Cost of goods sold
14,98 m
14,63 m
22,60 m
-
Cost of revenue
14,98 m
14,63 m
22,60 m
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,42 m
5,68 m
5,90 m
5,12 m
Operating expense
13,07 m
36,36 m
33,50 m
10,31 m
Total operating expenses
28,06 m
50,99 m
56,11 m
10,31 m
Operating income
-12,87 m
-36,37 m
-31,93 m
-10,31 m
Other non operating income
-1,10 k
1,92 m
897,00 k
399,00 k
EBT including unusual items
-14,80 m
-36,22 m
-32,80 m
-13,27 m
EBT excluding unusual items
-14,80 m
-36,22 m
-32,80 m
-13,27 m
Income tax expense
-1,90 m
-10,34 m
-9,61 m
-3,41 m
Effective tax rate
12,82%
28,53%
29,30%
25,71%
Other operating expenses
5,89 m
28,69 m
25,74 m
3,31 m
Net income
-12,90 m
-25,88 m
-23,19 m
-9,86 m
Net profit margin
-84,96%
-176,99%
-95,91%
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1,93 m
-1,78 m
-1,77 m
-3,36 m
Net interest expenses
-1,93 m
-1,78 m
-1,77 m
-3,36 m
Depreciation and amortization charges
1,76 m
1,99 m
1,87 m
1,88 m
EBITDA
-11,02 m
-34,49 m
-30,08 m
-8,43 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme